Young blood for old brains and the quest to slow brain aging

Young blood for old brains and the quest to slow brain aging

Aging leads to the degradation of function in nearly all tissues and organs. This process is marked by significant shifts in gene expression and changes in concentrations of all types of biological molecules. Recent technological progress has allowed biologists to measure an unprecedented number of these molecules throughout an organism, providing unique insights into the physiological and pathological conditions of cells and organs, including the aging process.

Large-scale proteomic studies in humans demonstrate dramatic shifts in the composition of the blood and cerebrospinal fluid proteomes with age allowing researchers to estimate brain age and identify proteins linked to cognitive decline, neurodegeneration, and dementia. While brain cell- and tissue-intrinsic factors are likely essential in driving the aging process, we find blood-borne factors from young humans and mice are sufficient to counteract aspects of brain aging and improve cognitive function in old mice, while blood plasma from old organisms is detrimental to young mice and impairs their cognition. These findings open opportunities to identify biomarkers and regulators of aging in general and for the brain and other organs specifically.

Image of Dr Tony Wyss

Tony Wyss-Coray, PhD

D.H. Chen Professor of Neurology and Neurological Sciences
Director, Phil and Penny Knight Initiative for Brain Resilience
Stanford University

Tony Wyss-Coray, PhD, is the D.H. Chen Distinguished Professor of Neurology and Neurological Sciences and the Director of the Phil and Penny Knight Initiative for Brain Resilience at Stanford University. His lab studies brain aging and neurodegeneration, with a focus on age-related cognitive decline and Alzheimer’s disease.

The Wyss-Coray research team discovered that circulatory blood factors can modulate brain structure and function, and factors from young organisms can rejuvenate old brains. Current studies focus on the molecular basis of the systemic communication with the brain by employing a combination of genetic, cell biology, and omics approaches in killifish, mice, and humans.

Wyss-Coray has presented his ideas at Global TED, the Tencent WE Summit, the World Economic Forum, and he was voted Time Magazine’s “The Health Care 50” most influential people transforming health care in 2018. He co-founded Alkahest and several other companies targeting Alzheimer’s and neurodegeneration and has been the recipient of an NIH Director’s Pioneer Award, a Zenith Award from the Alzheimer’s Association, and a NOMIS Foundation Award.

Young blood for old brains and the quest to slow brain aging

A presentation by Tony Wyss-Coray, PhD

 

Share with colleagues

More webinars

WebinarPathways to Digital Health: AI and Omics in Rheumatoid Arthritis

Explore how groundbreaking proteomic research is transforming our understanding of rheumatoid arthritis (RA). In this on-demand webinar, Allan Stensballe, PhD, shares new insights into the molecular landscape of RA-affected synovial tissue, revealing how autoantibodies and protein signatures may hold the key to more precise personalized therapies.

Learn more

WebinarUsing Antibody Profiling to Identify Novel Diagnostic Biomarkers

Current cancer screening methods often lead to false positives, false negatives and invasive biopsies that lack prognostic insights. Emerging research suggests that cancer-specific IgM and IgG antibodies – produced by B cells upon recognizing malignant cells – could serve as stable, easily measurable blood biomarkers for detecting and monitoring high-incidence cancers like melanoma and breast, prostate, bowel, lung and pancreatic cancer. This approach has the potential to improve early diagnosis, reduce uncertainty and enhance treatment planning.

Learn more

WebinarLinking the plasma proteome to echocardiographic parameters in patients with chronic heart failure

Recent advancements in proteomic profiling have unlocked new possibilities for understanding the complex mechanisms that drive heart failure. Measuring thousands of proteins simultaneously makes it possible to capture a comprehensive overview of the patient's health state and investigate underlying disease progression at a subclinical level.

Learn more

Explore webinars in our interactive viewer